We are live on
!
Find out more
Cardiff Oncology
CRDF
CRDF
67 hedge funds and large institutions have $264M invested in Cardiff Oncology in 2020 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
971% more capital invested
Capital invested by funds: $24.7M → $264M (+$240M)
760% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 5
400% more funds holding in top 10
Funds holding in top 10: 1 → 5 (+4)
131% more funds holding
Funds holding: 29 → 67 (+38)
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
50.19% more ownership
Funds ownership: 24.66% → 74.84% (+50%)
4% less call options, than puts
Call options by funds: $8.46M | Put options by funds: $8.85M
Holders
67
Holders Change
+38
Holders Change %
+131.03%
% of All Funds
1.35%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.1%
New
43
Increased
12
Reduced
6
Closed
5
Calls
$8.46M
Puts
$8.85M
Net Calls
-$384K
Net Calls Change
-$384K
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$21.7M |
| 2 |
VA
VR Adviser
New York
|
+$8.4M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$7.54M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$6.69M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.47M |
